Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma
Journal Article
·
· Henry Ford Hospital Medical Journal; (USA)
OSTI ID:6642292
Recently developed radiopharmaceuticals have been proposed for imaging medullary thyroid carcinoma (MTC) with some having therapeutic potential. This study compares the imaging results obtained with radioiodinated meta-iodo-benzylguanidine (MIBG), {sup 99m}Tc (V) DMSA, and {sup 131}I F(ab')2 anti-carcinoembryonic antigen (anti-CEA) in a group of MTC patients. In 23 patients {sup 131}I MIBG imaging showed a high specificity (no false-positive results) but a less satisfactory sensitivity (50%). In 12 patients {sup 99m}Tc (V) DMSA revealed a better sensitivity (77%) but a lower specificity (three false-positive results). Positive results were obtained in two of three patients studied with {sup 131}I F(ab')2 anti-CEA. These data suggest that the highly sensitive {sup 99m}Tc (V) DMSA should be considered as a first choice procedure followed by the highly specific radioiodinated MIBG to confirm the initial results. Since radioiodinated MIBG imaging may have therapeutic usefulness, {sup 131}I MIBG was evaluated in an integrated treatment protocol in four cases of proven MTC. The preliminary results obtained were encouraging.
- OSTI ID:
- 6642292
- Journal Information:
- Henry Ford Hospital Medical Journal; (USA), Journal Name: Henry Ford Hospital Medical Journal; (USA) Vol. 37:3-4; ISSN HFHJA; ISSN 0018-0416
- Country of Publication:
- United States
- Language:
- English
Similar Records
Localization of metastases from medullary thyroid carcinoma using different methods
New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma
Pentavalent (/sup 99m/Tc)DMSA, (/sup 131/I)MIBG, and (/sup 99m/Tc)MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid
Journal Article
·
Sat Dec 31 23:00:00 EST 1988
· Henry Ford Hospital Medical Journal; (USA)
·
OSTI ID:6609440
New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma
Journal Article
·
Mon Feb 29 23:00:00 EST 1988
· Clin. Nucl. Med.; (United States)
·
OSTI ID:6840690
Pentavalent (/sup 99m/Tc)DMSA, (/sup 131/I)MIBG, and (/sup 99m/Tc)MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid
Journal Article
·
Thu Dec 31 23:00:00 EST 1987
· J. Nucl. Med.; (United States)
·
OSTI ID:5400946
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMALS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARCINOMAS
CEA
COMPARATIVE EVALUATIONS
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC USES
DISEASES
DRUGS
ENDOCRINE GLANDS
FRENCH ORGANIZATIONS
GLANDS
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MAMMALS
MAN
MEDICINE
NATIONAL ORGANIZATIONS
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PRIMATES
RADIOISOTOPES
RADIOLOGY
RADIOPHARMACEUTICALS
RADIOTHERAPY
TECHNETIUM 99
TECHNETIUM ISOTOPES
THERAPEUTIC USES
THERAPY
THYROID
USES
VERTEBRATES
YEARS LIVING RADIOISOTOPES
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMALS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARCINOMAS
CEA
COMPARATIVE EVALUATIONS
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC USES
DISEASES
DRUGS
ENDOCRINE GLANDS
FRENCH ORGANIZATIONS
GLANDS
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MAMMALS
MAN
MEDICINE
NATIONAL ORGANIZATIONS
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PRIMATES
RADIOISOTOPES
RADIOLOGY
RADIOPHARMACEUTICALS
RADIOTHERAPY
TECHNETIUM 99
TECHNETIUM ISOTOPES
THERAPEUTIC USES
THERAPY
THYROID
USES
VERTEBRATES
YEARS LIVING RADIOISOTOPES